Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06387381
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-04-24
Brief Title:
68Ga-PSFA PET Imaging in Patients With PSMAFAP Positive Disease
Sponsor:
First Affiliated Hospital of Chongqing Medical University
Organization:
First Affiliated Hospital of Chongqing Medical University
Study Overview
Official Title:
68Ga-PSFA PET Imaging in Patients With PSMAFAP Positive Disease
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
As a new dual receptor PSMA and FAP targeting PET radiotracer 68Ga-PSFA is promising as an excellent imaging agent applicable to PSMAFAP positive diseases In this research we investigate the safety biodistribution and potential usefulness of 68Ga-PSFA positron emission tomography PET for the diagnosis of lesions in PSMAFAP positive diseases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None